PUBLISHER: Allied Market Research | PRODUCT CODE: 1097626
PUBLISHER: Allied Market Research | PRODUCT CODE: 1097626
The global capsule endoscopy system market was valued at $616.57 million in 2020, and is projected to reach $2.0 billion by 2030, growing at a CAGR of 12.4% from 2021 to 2030.
Capsule endoscopes are tiny wireless endoscopic systems that capture images of the body's interior. The endoscopic camera is small enough to fit in a vitamin capsule and can capture hundreds of images, which are subsequently sent to the recorder. Physicians can use capsule endoscopes to acquire images of parts of the body that a regular endoscope cannot reach. It is a technique used for the diagnosis and monitoring of gastrointestinal disorders, including small bowel diseases, colonic diseases, and esophageal diseases using wireless video capsule, data recorder, software, and workstations
Major factors that drive the growth of the global capsule endoscopy systems market include rise demand for minimally invasive diagnostic procedures, increase in prevalence of cancer, growth in geriatric population, and surge in introduction of technologically advanced capsules. However, high cost of treatments and endoscopy equipment, limited reimbursement, and the risk of retention of the capsule may require endoscopic retrieval or rarely surgical resection restrain the market growth. Conversely, many innovative and technologically advanced products gain commercialization during the forecast period, owing to increase in R&D activities of key market players.
The global capsule endoscopy systems market is segmented on the basis of component, disease, and region. According to component, it is divided into capsule endoscopes and recorders & workstations. Depending on disease, it is divided into small intestine disorder, esophageal disorder, and colonic disorder. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA).
The major companies profiled in the report include: Given Imaging (Medtronic), IntroMedic Co., Ltd., Olympus Corporation, Chongqing Jinshan Science & Technology (Group) Co., Ltd., RF System lab, CapsoVision, Shengxian Minimal Invasive Inc., Check -Cap, Accuread Endoscopy Inc., Fujifilm Holding Corporation, and Anhan Technology (wuhan) co., Ltd.
Key Benefits For Stakeholders
By Component
By Disease Type
By Region